What is the appropriate evaluation and management for a patient with macrocytosis and erythrocytosis?

Evaluation and Management of Macrocytosis with Erythrocytosis

Begin by measuring serum erythropoietin (EPO) level to distinguish primary from secondary erythrocytosis, then evaluate for vitamin B12 and folate deficiency as the most common causes of macrocytosis, while simultaneously screening for JAK2 mutation if EPO is low or if thrombocytosis/leukocytosis is present.

Initial Diagnostic Approach

The combination of enlarged red blood cells (macrocytosis, MCV >100 fL) with increased red blood cell mass (erythrocytosis) requires a systematic evaluation that addresses both abnormalities simultaneously 1, 2.

First-Line Laboratory Testing

Obtain the following tests immediately:

• Complete blood count with differential - Look specifically for:

  • Leukocytosis or thrombocytosis (suggests polycythemia vera)
  • Reticulocyte count (low/normal suggests deficiency; elevated suggests hemolysis)
  • Red cell distribution width (RDW) - elevated in B12/folate deficiency 3

• Serum erythropoietin level - This is the critical branching point 1, 2:

  • Low EPO → Primary erythrocytosis (polycythemia vera or other myeloproliferative neoplasm)
  • Normal or elevated EPO → Secondary erythrocytosis

• Vitamin B12 and folate levels - These are the most common causes of macrocytosis, accounting for 24% of cases 3, 4

• Peripheral blood smear - Look for:

  • Hypersegmented neutrophils (86% sensitive for megaloblastic anemia) 3
  • Macro-ovalocytes (72% sensitive for megaloblastic anemia) 3

• Serum ferritin and transferrin saturation 4

• CRP or inflammatory markers 4

Algorithmic Decision Tree

If EPO is LOW:

Test for JAK2 mutation immediately 1, 2. This indicates primary erythrocytosis, most commonly polycythemia vera. The macrocytosis may be coincidental or related to the myeloproliferative process itself 5.

• If JAK2 positive → Diagnose polycythemia vera, refer to hematology
• If JAK2 negative → Consider other myeloproliferative neoplasms or congenital causes; refer to hematology for bone marrow biopsy and molecular testing 1

If EPO is NORMAL or ELEVATED:

This indicates secondary erythrocytosis. Now focus on the macrocytosis etiology:

1. Evaluate for nutritional deficiencies 4:

• B12 deficiency (serum B12 <200 pg/mL or methylmalonic acid elevated):

  • In absence of inflammation: ferritin <30 μg/L indicates iron deficiency 4
  • With inflammation: ferritin <100 μg/L may still indicate iron deficiency 4
  • Critical pitfall: 21% of B12 deficiency presents with isolated macrocytosis WITHOUT anemia 3

• Folate deficiency (serum folate <4 ng/mL)

2. Medication review - Macrocytosis occurs with 4, 3:

• Thiopurines (azathioprine, 6-mercaptopurine)
• Hydroxyurea
• Methotrexate
• SGLT2 inhibitors (cause erythrocytosis) 6
• Androgens (cause erythrocytosis) 7

3. Evaluate secondary causes of erythrocytosis 2, 7, 6:

• Chronic hypoxia: Pulse oximetry, arterial blood gas, sleep study if indicated
• Smoking history: Carboxyhemoglobin level
• Renal pathology: Creatinine, renal ultrasound for masses
• Liver disease: Liver function tests, hepatic imaging
• Endocrine: Thyroid function tests (hypothyroidism causes macrocytosis)

4. Alcohol use - This is the single most common cause of macrocytosis (36.5% of cases) 3. Obtain detailed alcohol history and consider liver function tests.

Management Based on Findings

For Vitamin B12 Deficiency with Macrocytosis:

Patients with compromised B12 absorption require lifelong supplementation: either 350 μg daily oral cobalamin OR intramuscular injections of 1000-2000 μg every 1-3 months 8.

For acute symptomatic deficiency: Start with 1000 μg IM every other day for 2 weeks (or daily for 5 days), then continue at least twice monthly until resolution of macrocytosis 8.

Monitor serum potassium during repletion therapy 8.

For Secondary Erythrocytosis:

Treatment should target the underlying cause 2, 6. There are no clear guidelines for target hematocrit in secondary erythrocytosis, but consider phlebotomy if:

• Hematocrit >65% with hyperviscosity symptoms (headache, visual changes, poor concentration) 9
• Critical warning: Avoid routine repeated phlebotomies as they deplete iron stores, reduce oxygen-carrying capacity, and increase stroke risk 9

For Polycythemia Vera (if diagnosed):

Refer to hematology for management with phlebotomy, low-dose aspirin, and cytoreductive agents 6.

Common Pitfalls to Avoid

1. Do not assume macrocytosis requires anemia - 21% of B12 deficiency presents without anemia 3. Evaluate macrocytosis even when hemoglobin is normal or elevated.

2. Do not perform routine phlebotomy in secondary erythrocytosis - Only indicated for severe symptoms with hematocrit >65% 9.

3. Do not miss combined deficiencies - Ferritin 30-100 μg/L with inflammation suggests both iron deficiency AND anemia of chronic disease 4.

4. Do not overlook medication-induced macrocytosis - Thiopurines commonly cause macrocytosis without other hematologic abnormalities 4.

5. In young patients or those with family history, consider congenital causes and refer to hematology for specialized molecular testing 1, 2.

When to Refer to Hematology

• JAK2 mutation positive or low EPO level
• No identifiable secondary cause after systematic evaluation
• Young age (<40 years) or family history suggesting hereditary erythrocytosis 1, 2
• Concurrent unexplained leukocytosis or thrombocytosis
• Persistent macrocytosis after treating nutritional deficiencies